# K021581: Hemosorb

- Pathway: 510(k) (Traditional)
- Applicant: On Site Gas Systems, Inc.
- Decided: Jul 12, 2002 after 59 days
- Product code: QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K965034 (1998). 1 ancestor in all.
40 later devices descend from it; 2 cite it directly.
0 of 42 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K965034: Sorbastace, Hemostace, LLC (1998) Summary page 6.

## Most influential descendants
- K070010: Quikclot Sport and Quikclot Sport Silver (2007), 38 descendants of its own
- K072474: Quikclot EX (2007), 36 descendants of its own
- K090026: Chitogauze, Models 130, 131, 263, 264, 265, 266 (2009), 20 descendants of its own
- K092357: Chitogauze,2 in X 2 in,8 Ply, 4 in X 4 in 8 Ply, 4 in X 8 in, 8PLY, 1 in X 4 in, 8PLY, Chitogauze, Packaging Strip, 1/2 (2009), 10 descendants of its own
- K102546: Chitogauze (2010), 9 descendants of its own

## Indications for use
Hemosorb is intended as a topical dressing for the local management of bleeding wounds such as minor cuts, lacerations, and abrasions.

Source page: https://510kreport.com/device/K021581
Methodology: https://510kreport.com/methodology